OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies
Andrés Chang, Jean L. Koff, Lilin Lai, et al.
Blood Advances (2023) Vol. 7, Iss. 11, pp. 2459-2462
Open Access | Times Cited: 12
Andrés Chang, Jean L. Koff, Lilin Lai, et al.
Blood Advances (2023) Vol. 7, Iss. 11, pp. 2459-2462
Open Access | Times Cited: 12
Showing 12 citing articles:
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
COVID-19 Treatments: Then and Now
S. Shahzad Mustafa, Rebecca A. Stern, Pratish C Patel, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 11, pp. 3321-3333
Closed Access | Times Cited: 4
S. Shahzad Mustafa, Rebecca A. Stern, Pratish C Patel, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 11, pp. 3321-3333
Closed Access | Times Cited: 4
Pre-exposure prophylaxis with tixagevimab/cilgavimab for coronavirus disease 2019 (COVID-19) during the Omicron BA.5 wave at a single institution in Japan
Ichiro Kawashima, Hideto Hyuga, Ayato Nakadate, et al.
International Journal of Hematology (2023) Vol. 118, Iss. 6, pp. 731-736
Closed Access | Times Cited: 4
Ichiro Kawashima, Hideto Hyuga, Ayato Nakadate, et al.
International Journal of Hematology (2023) Vol. 118, Iss. 6, pp. 731-736
Closed Access | Times Cited: 4
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era
Ioannis Ntanasis‐Stathopoulos, Charalampos Filippatos, Maria Gavriatopoulou, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 123-123
Open Access | Times Cited: 3
Ioannis Ntanasis‐Stathopoulos, Charalampos Filippatos, Maria Gavriatopoulou, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 123-123
Open Access | Times Cited: 3
Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab
Victoria Hall, Thi H. O. Nguyen, Lilith F. Allen, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 11
Open Access | Times Cited: 2
Victoria Hall, Thi H. O. Nguyen, Lilith F. Allen, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 11
Open Access | Times Cited: 2
Prolonged Viral Shedding in Cancer Patients with Asymptomatic or Mild Omicron Infection: A Retrospective Study
Qiao Yang, Ying He, Yi Zhou, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 7735-7741
Open Access | Times Cited: 2
Qiao Yang, Ying He, Yi Zhou, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 7735-7741
Open Access | Times Cited: 2
Inactivated Vaccine Dosage and Serum IgG Levels Correlate with Persistent COVID-19 Infection in Hematologic Malignancy Patients During the Omicron Surge in China
Ye Li, Ye Yang, Xuewu Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Ye Li, Ye Yang, Xuewu Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic
Thamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, et al.
Molecular Biotechnology (2024)
Closed Access
Thamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, et al.
Molecular Biotechnology (2024)
Closed Access
Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron Surge in China
Ye Li, Ye Yang, Xuewu Zhang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Ye Li, Ye Yang, Xuewu Zhang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Impact of Evusheld monoclonal antibodies on incidence and severity of COVID-19 in patients with cancer: A retrospective cohort study
Fatima Warraich, Priya Bhardwaj, Maryam Naser, et al.
Research Square (Research Square) (2024)
Closed Access
Fatima Warraich, Priya Bhardwaj, Maryam Naser, et al.
Research Square (Research Square) (2024)
Closed Access
Rapid screening methods for universal binding peptide aptamers against SARS-CoV-2 variant spikes, including omicron variants, and their application to diagnostic and therapeutic agents.
Nakanobu Hayashi
Research Square (Research Square) (2023)
Closed Access
Nakanobu Hayashi
Research Square (Research Square) (2023)
Closed Access
Rapid screening methods for universal binding peptide aptamers against SARS-CoV-2 variant spikes, including omicron variants, and their application to diagnostic and therapeutic agents.
Nakanobu Hayashi, Chikako Abe, Jiro Kikuchi, et al.
Research Square (Research Square) (2023)
Closed Access
Nakanobu Hayashi, Chikako Abe, Jiro Kikuchi, et al.
Research Square (Research Square) (2023)
Closed Access
